Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters








Database
Language
Publication year range
1.
Oncogene ; 37(8): 1107-1118, 2018 02 22.
Article in English | MEDLINE | ID: mdl-29155422

ABSTRACT

High-grade gliomas (HGGs) include the most common and the most aggressive primary brain tumor of adults and children. Despite multimodality treatment, most high-grade gliomas eventually recur and are ultimately incurable. Several studies suggest that the initiation, progression, and recurrence of gliomas are driven, at least partly, by cancer stem-like cells. A defining characteristic of these cancer stem-like cells is their capacity to self-renew. We have identified a hypoxia-induced pathway that utilizes the Hypoxia Inducible Factor 1α (HIF-1α) transcription factor and the JAK1/2-STAT3 (Janus Kinase 1/2 - Signal Transducer and Activator of Transcription 3) axis to enhance the self-renewal of glioma stem-like cells. Hypoxia is a commonly found pathologic feature of HGGs. Under hypoxic conditions, HIF-1α levels are greatly increased in glioma stem-like cells. Increased HIF-1α activates the JAK1/2-STAT3 axis and enhances tumor stem-like cell self-renewal. Our data further demonstrate the importance of Vascular Endothelial Growth Factor (VEGF) secretion for this pathway of hypoxia-mediated self-renewal. Brefeldin A and EHT-1864, agents that significantly inhibit VEGF secretion, decreased stem cell self-renewal, inhibited tumor growth, and increased the survival of mice allografted with S100ß-v-erbB/p53-/- glioma stem-like cells. These agents also inhibit the expression of a hypoxia gene expression signature that is associated with decreased survival of HGG patients. These findings suggest that targeting the secretion of extracellular, autocrine/paracrine mediators of glioma stem-like cell self-renewal could potentially contribute to the treatment of HGGs.


Subject(s)
Biomarkers, Tumor/metabolism , Brain Neoplasms/pathology , Glioma/pathology , Hypoxia/physiopathology , Neoplastic Stem Cells/pathology , STAT3 Transcription Factor/metabolism , Animals , Apoptosis , Biomarkers, Tumor/genetics , Brain Neoplasms/genetics , Brain Neoplasms/metabolism , Cell Proliferation , Female , Glioma/genetics , Glioma/metabolism , Hypoxia-Inducible Factor 1, alpha Subunit/genetics , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Janus Kinase 1/genetics , Janus Kinase 1/metabolism , Janus Kinase 2/genetics , Janus Kinase 2/metabolism , Mice , Neoplastic Stem Cells/metabolism , Neovascularization, Pathologic , STAT3 Transcription Factor/genetics , Tumor Cells, Cultured
2.
J Biol Chem ; 276(30): 28261-7, 2001 Jul 27.
Article in English | MEDLINE | ID: mdl-11375993

ABSTRACT

Osteopontin (OPN) is a secreted phosphoprotein shown to function in wound healing, inflammation, and tumor progression. Expression of OPN is often co-localized with members of the matrix metalloproteinase (MMP) family. We report that OPN is a novel substrate for two MMPs, MMP-3 (stromelysin-1) and MMP-7 (matrilysin). Three cleavage sites were identified for MMP-3 in human OPN, and two of those sites were also cleaved by MMP-7. These include hydrolysis of the human Gly166-Leu167, Ala201-Tyr202 (MMP-3 only), and Asp210-Leu211 peptide bonds. Only the N-terminal Gly-Leu cleavage site is conserved in rat OPN (Gly151-Leu152). These sites are distinct from previously reported cleavage sites in OPN for the proteases thrombin or enterokinase. We found evidence for the predicted MMP cleavage fragments of OPN in vitro in tumor cell lines, and in vivo in remodeling tissues such as the postpartum uterus, where OPN and MMPs are co-expressed. Furthermore, cleavage of OPN by MMP-3 or MMP-7 potentiated the function of OPN as an adhesive and migratory stimulus in vitro through cell surface integrins. We predict that interaction of MMPs with OPN at tumor and wound healing sites in vivo may be a mechanism of regulation of OPN bioactivity.


Subject(s)
Matrix Metalloproteinase 3/metabolism , Matrix Metalloproteinase 7/metabolism , Sialoglycoproteins/metabolism , Amino Acids/chemistry , Animals , Binding Sites , Blotting, Western , CHO Cells , Cell Adhesion , Cell Movement , Cricetinae , Dose-Response Relationship, Drug , Female , HeLa Cells , Humans , Immunoblotting , In Situ Hybridization , Integrins/metabolism , Matrix Metalloproteinase 3/chemistry , Matrix Metalloproteinase 7/chemistry , Models, Chemical , Osteopontin , Peptides/chemistry , Protein Binding , Rats , Recombinant Proteins/metabolism , Sialoglycoproteins/chemistry , Signal Transduction , Substrate Specificity , Uterus/metabolism , Wound Healing
SELECTION OF CITATIONS
SEARCH DETAIL